The word recession is on the tip of everyone’s tongue. Influential investor and philanthropist George Soros is talking about it in Davos. The Federal Reserve, on the day minutes are published, is cons...
Tag: Biotech and Pharma
BioNTech Earnings Top Forecasts on Strong Sales of Covid-19 Vaccine
Text size BioNTech is continuing to work with Pfizer on follow-on Covid-19 vaccines. (Photo by THOMAS LOHNES/AFP via Getty Images) BioNTech , the German biotech company, reported first-quarter earning...
Big Pharma Has Enough Cash to Buy All of Biotech. Why M&A Isn’t Happening.
Text size Late last year, Barron’s predicted a wave of deals, citing biotech companies’ cash holdings. Above, the plates used to print one-dollar bills. Alex Wong/Getty Images With biotech...
Bausch + Lomb, Year’s Second-Biggest IPO, Pops in Public Debut
Text size Bausch + Lomb’s IPO is the second-biggest so far this year. Scott Olson/Getty Images Eye-care company Bausch + Lomb and biotech PepGen kicked off their lives as public companies Friday...
Illumina Stock Plunges Despite Strong Results, Gene-Sequencing Sales
Text size Illumina turned in stronger financial results than expected. Dreamstime The gene-sequencing supplier Illumina delivered on its March quarter financial forecasts, as global demand for genetic...
Pfizer’s New CFO David Denton Negotiated One of the Biggest Healthcare Deals in History
Pfizer on Monday named a new chief financial officer with a resume that hints at the company’s plans to spend big with its Covid-19 vaccine windfall. David Denton is taking up the CFO role at Pfizer (...
Walgreens Earnings Top Estimates but Its Outlook Crushes the Stock.
Text size Walgreens delivers a second-quarter earnings beat. (Photo by Justin Sullivan/Getty Images) Justin Sullivan/Getty Images Walgreens Boots Alliance tumbled Thursday after investors were disappo...
Carl Icahn Slashes Stake in Occidental Petroleum
Text size These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities....
Novavax’s Revenue Falls Short. Management Expects a Surge.
Text size A doctor handles a vial holding a potential coronavirus vaccine at a Novavax lab in 2020. Andrew Caballero-Reynolds/AFP via Getty Images The Covid-19 vaccine maker Novavax expects sales of b...
Covid-19 Vaccine Makers Face a New Rival as GlaxoSmithKline and Sanofi Prepare to Enter the Ring
As new Covid-19 cases fall, the postpandemic vaccine market grows more interesting. On Wednesday, GlaxoSmithKline and Sanofi, two of the world’s largest vaccine makers, said they would submit a Covid ...
Novavax Gets a Sell Rating. It’s Got a Covid Vaccine Problem, Analyst Says.
Text size A healthcare worker prepares a dose of Nuvaxovid vaccine. Jeroen Jumelet/ANP/AFP via Getty Images Novavax stock was dropping Friday after receiving a Sell-equivalent rating — the first since...